A detailed history of High Tower Advisors, LLC transactions in Dyadic International Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 79,569 shares of DYAI stock, worth $139,245. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,569
Previous 79,269 0.38%
Holding current value
$139,245
Previous $117,000 29.91%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.04 - $1.55 $312 - $465
300 Added 0.38%
79,569 $82,000
Q2 2024

Aug 13, 2024

BUY
$1.39 - $2.27 $2,710 - $4,426
1,950 Added 2.52%
79,269 $117,000
Q1 2024

May 06, 2024

BUY
$1.29 - $1.67 $99,741 - $129,122
77,319 New
77,319 $129,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $49.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.